Pre-ischemic treatment of pentoxifylline reduces infarct volumes in transient focal cerebral ischemia in the rat

Iranian Journal of Medical Sciences

Volumn 30, Issue 4, 2005, Pages 169-173

  Nekooeian, A A ^a   Vakili, A ^a   Dehghani, G A ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cerebral ischemia; Infarction; Pentoxifylline; TNF

Indexed keywords

PENTOXIFYLLINE; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; STAINING; TRANSIENT ISCHEMIC ATTACK;

EID: 31744440044     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Feuerstein GZ, Liu T, Barone FC. Cytokines, inflammation and brain injury: the role of tumor necrosis factor-α. Cerebrovasc Brain Metab Rev 1994; 6: 341-60.
2. Gregersen R, Lambertsen K, Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000; 20: 53-65.
3. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 1997; 17: 483-90.
4. Nawashiro H, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor and amelioriation of brain infarction in mice. J Cereb Blood Flow Metab 1997; 17: 229-32.
5. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-alpha a mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-44.
6. Yang GY, Gong C, Qin Z, et al. Inhibition of TNF-alpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 1998; 9: 2131-4.
7. Lavine SD, Hofman FM, Zlokovic BV. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J Cereb Blood Flow Metab 1998; 18: 52-8.
8. Dawson DA, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 1996; 218: 41-4.
9. Kim KS, Wass CA, Cross AS, Opal SM. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res 1992; 11: 293-8.
10. Megyeri P, Abraham CS, Temesvari P, et al. Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992; 14: 137-40.
11. Rosenberg GA, Dencoff JE, Correa N Jr, et al. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 1996; 46: 1626-32.
12. Robbins DS, Shirazi Y, Drysdale BE, et al. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987; 39: 2593-7.
13. Goldblum SE, Sun WL. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumen flux in vitro. Am J Physiol 1990, 285: L57-67.
14. Jacoby D, Mohler ER. Drug treatment of intermittent claudication. Drugs 2004, 64: 1657-70.
15. Muller R, Schroer R. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy. J Med 1979; 10: 347-64.
16. Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50-97.
17. Strieter RM, Remick DG, Ward PA, et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988; 155: 1230-6
18. Chao CC, Hu S, Close K, et al. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J Infect Dis 1992; 166: 847-53
19. Shohami E, Bass E, Wallach D, et al. Inhibition of tumor necrosis factor alpha activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 1996; 16: 378-84.
20. Sirin BH, Yilik L, Coskun E, et al. Pentoxifylline reduces injury of the brain in transient ischaemia. Acta Cardiol 1998; 53: 89-95.
21. Vakili A, Nekoueian AA, Dehghani GA. L-NAME and 7-nitroindazole reduces brain injuries in transient focal cerebral ischemia in rat. Iran J Med Sci 2004; 29: 109-15.
22. Vakili A, Kataoka H, Plesnila N. Role of arginine vasopressin v(1) and v(2) receptors for brain damage after focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 1038-43.
23. Eun BL, Liu XH, Barks JD. Pentoxifylline attenuates hypoxic-ischemic brain injury in immature rats. Pediatr Res 2000; 47: 73-8.
24. Banfi C, Sironi L, De Simoni G, et al. Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats. J Pharmacol Exp Ther 2004; 310: 890-5.
25. Brint S, Jacewicz M, Kiessling M, et.al. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988; 8: 474-85.
26. Swanson RA, Morton MT, Tsao-Wu G, et al. Semi automated method for measuring brain infarct volume. Cereb Blood Flow Metab 1990; 10: 290-3.
27. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 1999; 10: 119-30.
28. Zabel P, Wolter DT, Schonharting MM, Schade UF. Oxpentifylline in endotoxaemia. Lancet 1989; 2: 1474-7
29. Bruce AJ, Boling W, Kindy MS, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Medicine 1996; 2: 788-94.
30. Adams JG Jr, Dhar A, Shukla SD, Silver D. Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury. J Vasc Surg 1995; 21: 742-8.